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Abstract  
 
Background：Fucoidan is a complex sulfated polysaccharide extracted from brown seaweed and has a wide variety of 
biological activities. It not only inhibits cancer cell growth but also inhibits tyrosinase in vitro. Therefore, it is of 
interest to investigate the effect of fucoidan on B16 murine melanoma cells as the findings may provide new insights 
into the underlying mechanism regarding the inhibition of melanin formation by fucoidan. In the present study, we 
aimed to investigate the anti-melanogenic effect of fucoidan and its inhibitory effect on B16 cells. 
Materials and Methods: The influence of fucoidan on B16 melanoma cells and cellular tyrosinase was examined. Cell 
viability was examined by the cell counting kit-8 assay. Cellular tyrosinase activity and melanin content were 
determined using spectrophotometric methods and protein expression was analyzed by immunoblotting. Morphological 
changes in B16 melanoma cells were examined by phase contrast microscopy and apoptosis was analyzed by flow 
cytometry. 
Results: In vitro studies were performed using cell viability analysis and showed that fucoidan significantly decreased 
viable cell number in a dose-response manner with an IC50 of 550 ±4.3 µg/mL. Cell morphology was altered and 
significant apoptosis was induced when cells were exposed to 550 µg/mL fucoidan for 48 h. 
Conclusion: This study provides substantial evidence to show that fucoidan inhibits B16 melanoma cell proliferation 
and cellular tyrosinase activity. Fucoidan may be useful in the treatment of hyperpigmentation and as a skin-whitening 
agent in the cosmetics industry. 
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Introduction 
 
  Melanin synthesis is the most important function and differentiation characteristic of melanocytes. Melanin protects 
the skin from ultraviolet radiation damage; however, excess expression or uneven distribution of melanin may cause 
chloasma, freckles and post-inflammatory hyperpigmentation (de Fine Olivarius et al., 1999; Hearing, 2005; Mizusawa 
et al., 2011). Therefore, whitening agents have been widely used in cosmetics. The melanin synthesis pathway is a 
highly complex process regulated by enzymes such as tyrosinase, tyrosinase-related protein-1 and tyrosinase-related 
protein-2 (Fang et al., 2001; Negroiu et al., 2000; Ye et al., 2010; Lee et al., 2012). Tyrosinase hydroxylates tyrosine to 
form 3, 4-dihydroxyphenylalanine (DOPA). DOPA is then oxidized to dopamine quinone and dopachrome (Parvez et 
al., 2006). Tyrosinase is a key enzyme which catalyzes the rate-limiting step of melanin biosynthesis (Cooksey et al., 
1997; Hearing, 1999; Kim and Uyama, 2005). Therefore, research on whitening agents is mainly concentrated on 
tyrosinase inhibitors. 
  Previous studies have shown that fucoidan possesses diverse biological activities such as antilipidemic 
(Raghavendran et al., 2005), antithrombotic (Chandía et al., 2008; Zhao et al., 2016), inflammation modulation 
(Cumashi et al., 2007; Jin and Yu, 2015), antiviral (Hayashi et al., 2008), antitumor (Alekseyenko et al., 2007; Sun et 
al., 2016) and antioxidant (Wang et al., 2010; Saravana et al., 2016) activities. In our previous study, we found that 
fucoidan inhibited cell-free tyrosinase activity, and interacted with several residues including copper ions located in the 
active site (Wang et al., 2012). As fucoidan inhibits tyrosinase and has anti-cancer effects, an investigation on the effect 
of fucoidan on melanin formation in melanoma may produce some interesting results. Thus, the present study was 
undertaken to investigate the ability of fucoidan to inhibit cellular tyrosinase derived from melanin-producing B16 
melanoma cells and its ability to inhibit melanin formation. The effect of fucoidan on B16 melanoma cells was also 
determined.  
 
 
 
 
Wang et al., Afr J Tradit Complement Altern Med., (2017) 14 (4): 149-155 
https://doi.org/10.21010/ajtcam.v14i4.18 
 
150 
 
Materials and methods 
Materials 
 
  Fucoidan (from Fucus vesiculosus), and L-3,4-dihydroxyphenylalanine were purchased from Sigma. Triton X-100 
and dimethylsulfoxide were purchased from Sigma. Other compounds used in the study were obtained from Shanghai 
R&D Center for Standardization of Chinese Medicines (Shanghai, China, purity > 99%). 
 
Cell culture and treatment 
 
  B16 murine melanoma cells (Shanghai Institutes for Biological Science, Chinese Academy of Sciences, China) were 
grown in DMEM medium (Gibco, USA) supplemented with 10% fetal bovine serum (Sigma), 100 units/mL of 
penicillin (PAA, Austria) and 100 µg/mL of streptomycin (PAA, Austria) at 37◦C in a humidified atmosphere of 5% 
CO2. When the cells reached logarithmic growth phase, various concentrations of fucoidan were added to the cells and 
cultured 48 h.  
 
Cellular tyrosinase activity assay 
 
  Cellular tyrosinase activity was measured as previously described with some modifications (Lee et al., 2006). B16 
melanoma cells were seeded in 96-well plates (2×103cells/well) and allowed to adhere for 12 h at 37◦C. The cells were 
incubated with different doses of fucoidan for 48 h and then washed with PBS and lysed with mammalian protein 
extraction reagent (Pierce, Rockford, IL, USA). The lysates were then centrifuged at 17,500 g for 15 min at 4◦C. The 
protein concentration was determined by the Bradford method (Bio-Rad Laboratories Inc., Hercules, CA, USA). A 200 
µL mixture containing 40 µg protein was added to each well of the 96-well plate and incubated for 1 h at 37◦C with 2.5 
mM 3, 4-dihydroxy-L-phenylalanine (L-DOPA). The absorbance was measured using a microplate reader at 475 nm 
(BD Bioscience, USA).  
 
Measurement of cellular melanin content 
 
  Melanin content was measured as described previously with minor modifications (Jones et al., 2002). The cells were 
seeded in 60 mm dishes (2×103 cells/well) and allowed to adhere for 12 h at 37◦C and then exposed to different 
concentrations of fucoidan for 48 h, washed with PBS and then lysed in 150 mL of 1 M NaOH containing 10% 
dimethylsulfoxide for 1 h at 70◦C. The samples were placed in wells on a 96-well microplate, and the absorbance was 
measured at 405 nm with a Microplate Reader. The protein concentration in each sample was determined using the Bio-
Rad Protein Assay.  
 
Western blot analysis 
 
  A protein suspension was obtained using the method described above. The proteins were separated on SDS-
polyacrylamide gels (20 µg per sample) and transferred to polyvinylidene difluoride membranes and after blocking and 
washing were incubated with primary antibodies. The primary antibodies used were goat polyclonal antibodies against 
tyrosinase (Product number SC7833), tyrosinase-related protein-1 (TRP1) (Product number SC10443), rabbit 
polyclonal antibodies against tyrosinase-related protein-2 (TRP2) (Product number AB74073) and the microphthalmia-
associated transcription factor (MITF) (product number BS1550). Immunoreactivity was determined with secondary 
antibodies and enhanced chemiluminescence detection reagents (KGP 1123, Nanjing KeyGEN Biotechnology Co., Ltd., 
Nanjing, China) using a gel imaging system (ChemiScope 2850, Clinx Science Instruments Co., Let., Shanghai, China). 
β-Actin was used to adjust protein loading. 
 
Measurement of cell viability 
 
  Cell viability was determined using the cell counting kit-8 (CCK8) assay. Briefly, B16 melanoma cells were seeded 
in 96-well plates at a density of 2×103 cells/well and allowed to adhere for 12 h at 37◦C. After 200  L of substrate 
containing fucoidan (0, 100, 200, 300, 450, 500, 550 and 600 µg/mL) was added by changing the medium, the cells 
were incubated for 48 h. Substrate (200 µL) containing 10% CCK8 was added to each well by changing the medium, 
the cells were incubated for another 2.5 h and the absorbance was measured at 450 nm with a microplate reader 
(BioTeck, USA).  
 
Morphological changes in B16 melanoma cells   
 
  B16 murine melanoma cells in the logarithmic growth phase were inoculated into 6 wells of a glass cover plate for 
24 h, and then fucoidan was added to the cells with a final concentration of 0 µg/mL and 550 µg/mL. The cells were 
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then incubated for a further 48 h. Cell morphology and changes in morphology were observed by phase contrast 
microscopy. 
 
Measurement of apoptosis 
 
  B16 murine melanoma cells were incubated with 0 µg/mL and 550 µg/mL fucoidan for 48 h, respectively. The cells 
were digested by pancreatic enzyme, suspended in medium, washed with precooled PBS, and suspended in binding 
buffer. Then 5 µL Annexin V-FITC staining fluid and 10 µL PI staining fluid were added to the suspensions and 
incubated at room temperature away from light for 15 min. Apoptosis was analyzed by flow cytometry  BD 
Biosciences, USA).  
 
Results 
Effect of fucoidan on cellular tyrosinase activity and melanin synthesis in B16 cells 
 
 
 
 
Figure 1: Effect of fucoidan on cellular tyrosinase activity 
 
  In our earlier report, fucoidan significantly inhibited mushroom tyrosinase in a cell-free system with an IC50 of 11.5 
± 1.3 mg/mL (Wang et al., 2012). In the present study, fucoidan also inhibited tyrosinase. Cellular tyrosinase activity 
was reduced by fucoidan in a dose-dependent manner (Figure 1). The inhibitory concentration of fucoidan leading to 
50% activity loss (IC50) was estimated to be 550 ±4.3 µg/mL. When these results were compared with our earlier report 
(Wang et al., 2012), it was concluded that the ability of fucoidan to inhibit tyrosinase was different when tyrosinase was 
free in cells. These results demonstrated that the ability of fucoidan to inhibit cellular tyrosinase was much better than 
its ability to inhibit free tyrosinase. 
  The effect of fucoidan on melanin production in B16 melanoma cells was determined. Figure 2 shows that fucoidan 
reduced cellular melanin content in a dose-dependent manner. From Figure 1 and 2, it can be assumed that decreased 
tyrosinase activity reduced melanin synthesis as tyrosinase is the key enzyme in melanin synthesis. As fucoidan has 
antitumor activity, we determined whether fucoidan inhibited B16 murine melanoma cells. If the cells were inhibited by 
fucoidan then reduced melanin synthesis would be the result of both tyrosinase and cell inhibition. 
 
 
Figure 2: Effect of fucoidan on melanin content 
 
Effect of fucoidan on the expression of MITF, tyrosinase, TRP-1 and TRP-2 
 
   Melanin synthesis is stimulated by tyrosinase, TRP-1, and TRP-2, and MITF is the most important transcription 
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factor in the regulation of tyrosinase, TRP1 and TRP2 expression. These proteins were evaluated using western blotting 
after treatment with different fucoidan concentrations for 48 h. As shown in Figure 3, there was no obvious effect on 
TRP-1, TRP-2, and MITF expression, but the expression of tyrosinase and MITF were up-regulated. 
   
Figure 3: Effect of fucoidan on the expression of tyrosinase, TRP-1, TRP-2, MITF 
 
Effect of fucoidan on cell viability 
 
  To determine the effects of fucoidan on cellular melanin synthesis, cell viability was evaluated. The effects of 
different fucoidan concentrations (0–600 µg/mL) on the growth of B16 melanoma cells were assessed by measuring 
cell viability using the CCK-8 assay. The results of this experiment are shown in Figure 4. The growth of B16 
melanoma cells was affected in a dose-dependent manner following the addition of fucoidan. Fucoidan dose-
dependently reduced the number of viable cells present, with cell viability reduced to 46.37±2.6% following the 
addition of 600 µg/mL fucoidan. The IC50 was 530±3.32 µg/mL. Fucoidan not only inhibited tyrosinase activity, but 
also had a very good inhibitory effect on melanocytes (Figure 4). These results suggested that fucoidan is a very good 
whitening agent at the molecular level and cellular level. When the concentration of fucoidan was 500 µg/ml, cell 
viability was approximately 50.65%, and the cellular tyrosinase activity was 55.7%. These results were similar to those 
with kojic acid (Chan et al., 2011).  
 
Figure 4: Effect of fucoidan on B16 melanoma cells 
 
Effect of fucoidan on cell morphology  
 
  B16 melanoma cells were cultured with fucoidan (550 µg/mL) for 48 h, and then observed under a phase contrast 
microscope. B16 melanoma cells grew well in the control group. The cells were dense with regular growth. In contrast 
to the control, fucoidan treatment severely inhibited cell activity within 48 h, produced alterations in cell morphology, 
and removed the contact vegetative state. Fucoidan showed significant anti-melanocyte activity (Figure 5). 
          
(A)                             (B) 
Figure 5: Effects of fucoidan on B16 melanoma cells morphology 
(100 ×, scale bar 100 μm) 
（A）control group （B）experimental group (550 μg/ml fucoidan)     
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Induction of apoptosis in B16 melanoma cells 
 
  To determine the inhibitory effect of fucoidan on the proliferation of B16 cells, the rate of apoptosis in cells treated 
with different concentrations of fucoidan was determined by Annexin V-FITC/ PI staining and flow cytometry. The 
results showed that in cells incubated with 550 µg/mL fucoidan for 48 h, the apoptosis rate increased from 3.01±1.02% 
to 13.74±2.47% (Figure 6). This indicated that fucoidan significantly induced cell apoptosis.  
 
         
(A)                             (B) 
Figure 6: Induction effect of Fucoidan on B16 melanoma cells apoptosis  
（A）control group （B）experimental group (550 μg/mL fucoidan)  
Q1：non-viable non-apoptotic cell；Q2：viable apoptotic cell；Q3：Normal growth cell； 
Q4 ：non-viable apoptotic cell；Q2+Q4：apoptosis rate 
    
Discussion 
 
  We have previously reported on many tyrosinase inhibitors. A large number of experiments have suggested that 
inhibition of tyrosinase activity is the key to whitening, and as reported fucoidan is one of these inhibitors. Fucoidan 
effectively suppressed tyrosinase activity in the form of mixed inhibition (Wang et al., 2012). However, it was reported 
that polysaccharides or fucoidan had antitumor activity. Fucoidan has shown inhibitory effects on metastasis, 
angiogenesis and suppression of growth in a variety of cancer cells, such as human breast cancer cells, HT-29 colon 
cancers and HS-sultan human lymphoma cells (Aisa et al., 2005; Yamasaki-Miyamoto et al., 2009; Kim et al., 2010). 
Apoptosis may help to protect cells and avoid death. Cunha (2012) demonstrated that melanogenesis stimulation may 
prevent cell death in melanoma. Pinon et al. (2011) demonstrated that melanogenesis upregulation was beneficial in 
melanoma cells undergoing apoptosis, and apoptosis was able to delay cell death. 
  Tyrosinase is known to be a key enzyme, and is responsible for the rate-limiting step in melanin synthesis. It was 
demonstrated that the inhibitory effect on melanogenesis was associated with a decrease in tyrosinase activity (Cha et 
al., 2012; Chaabane et al., 2014). Jeong et al. (2015) showed that baicalin, a component of Scutellaria baicalensis 
decreased melanogenesis and tyrosinase activity. On the other hand, it was reported that tyrosinase was enhanced when 
melanogenesis increased ( Skandrani et al. 2010; Chaabane et al. 2013). 
  In this study, the results suggested that fucoidan increased the rate of melanoma cell apoptosis. However, melanin 
was beneficial for apoptosis, and as a result, cells may be induced to regulate the melanin synthesis pathway in order to 
produce more melanin leading to up-regulation of tyrosinase expression. The up-regulated tyrosinase protein can be 
stimulated to produce more melanin. But, fucoidan not only has anticancer activity, but is also a tyrosinase inhibitor. In 
this study, tyrosinase activity was significantly reduced with increased fucoidan dose. This indicated that fucoidan 
inhibited the biological activity of tyrosinase, and then reduced melanin content. 
    
Conclusions 
 
  In conclusion, based on the results obtained from our previous research and the present study, our major findings are 
as follows: (1) fucoidan inhibited the proliferation of B16 melanoma cells; (2) fucoidan up-regulated tyrosinase 
expression. In addition, fucoidan also inhibited B16 murine melanoma cellular tyrosinase activity, and the inhibition of 
B16 murine cellular tyrosinase was greater than that of cell-free mushroom tyrosinase as previously reported. Fucoidan 
not only induced melanin cell apoptosis but also efficiently inhibited extracellular tyrosinase. Fucoidan may be a very 
good whitening agent.  
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